CIK 0000876343 · Non-accelerated filer<br>Smaller reporting company
Lineage Cell Therapeutics, Inc.
Sign in to watch- Ticker
- LCTX
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 943127919
- Phone
- 5105213390
- Business address
- 2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
- Former names
- BIOTIME INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-11 | Culley Brian M President and CEO | Option exercise | +31,249 | 139,143 | ||
| 2023-02-11 | Culley Brian M President and CEO | Shares withheld for taxes | −12,744 | $1.35 | $17K | 126,399 |
| 2023-02-11 | Culley Brian M President and CEO | Option exercise · Restricted Stock Units | −31,249 | 93,748 | ||
| 2023-02-11 | Hogge Gary S. SVP,Clinical & Medical Affairs | Option exercise | +13,020 | 13,020 | ||
| 2023-02-11 | Hogge Gary S. SVP,Clinical & Medical Affairs | Shares withheld for taxes | −5,310 | $1.35 | $7K | 7,710 |
| 2023-02-11 | Hogge Gary S. SVP,Clinical & Medical Affairs | Option exercise · Restricted Stock Units | −13,020 | 39,061 | ||
| 2022-11-14 | Howe Jill Ann Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +1,000,000 | 1,000,000 | ||
| 2022-07-01 | Amin Dipti Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2022-07-01 | Russell Angus C. Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2022-07-01 | ANDREWS DEBORAH J Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2022-07-01 | Jayasuriya Anula Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2022-07-01 | Mulroy Michael H. Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2022-07-01 | KINGSLEY ALFRED D Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2022-07-01 | BAILEY DON M Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2022-07-01 | BRADSHER NEAL C Director | Grant or award · OPTION TO PURCHASE COMMON SHARES | +50,000 | 50,000 | ||
| 2022-06-30 | Culley Brian M President and CEO | Option exercise | +15,450 | 113,237 | ||
| 2022-06-30 | Culley Brian M President and CEO | Shares withheld for taxes | −5,343 | $1.58 | $8K | 107,894 |
| 2022-06-30 | Culley Brian M President and CEO | Option exercise · Restricted Stock Units | −15,450 | 0 | ||
| 2022-03-31 | Culley Brian M President and CEO | Option exercise | +15,450 | 96,730 | ||
| 2022-03-31 | Culley Brian M President and CEO | Shares withheld for taxes | −5,343 | $1.54 | $8K | 91,387 |
Page 5 of 8 · 153 trades